MétaCan
Menu
Back to cohort
Record W4412458458 · doi:10.1093/jac/dkaf231

Trimethoprim/sulfamethoxazole and risk of haemophagocytic lymphohistiocytosis (HLH): a literature review and disproportionality analysis using individual case safety reports from FAERS

2025· review· en· W4412458458 on OpenAlexaff
Hasti Sadeghi, Fatemeh Ahmadi, Niaz Chalabianloo, Rebecca Preyra, Mohammad Ali Omrani, Flory T. Muanda

Bibliographic record

VenueJournal of Antimicrobial Chemotherapy · 2025
Typereview
Languageen
FieldMedicine
TopicAutoimmune and Inflammatory Disorders Research
Canadian institutionsLondon Health Sciences CentreLawson Health Research InstituteWestern University
Fundersnot available
KeywordsTrimethoprimSulfamethoxazoleMedicineAzithromycinAdverse Event Reporting SystemOdds ratioInternal medicineAdverse effectPediatricsAntibioticsMicrobiology

Abstract

fetched live from OpenAlex

OBJECTIVES: This study aimed to review existing literature regarding the association between haemophagocytic lymphohistiocytosis (HLH) and trimethoprim/sulfamethoxazole and examine the risk of HLH using data from the FDA Adverse Event Reporting System (FAERS). METHODS: We conducted a literature review to identify studies investigating the link between trimethoprim/sulfamethoxazole and HLH. Additionally, we performed an active-comparator restricted disproportionality analysis (ACR-DA) in FAERS (2004Q1-2023Q4) for trimethoprim/sulfamethoxazole compared to amoxicillin/clavulanate and azithromycin. We calculated reporting odds ratios (ROR), adjusted ROR (accounting for age category and indications for respiratory and urinary tract infections), proportional reporting ratios and information components (IC25), to identify potential safety signals for HLH. RESULTS: Our literature review identified five case reports of HLH linked to trimethoprim/sulfamethoxazole, showing a male predominance of 80% and a median age of 39 years. Symptoms appeared 2 to 14 days after initiating treatment, with fever being the first symptom reported in all patients. The disproportionality analysis indicated that reports of HLH associated with trimethoprim/sulfamethoxazole were approximately 3 to 14 times more frequent than those for amoxicillin/clavulanate (ROR, 3.08; 95% CI, 1.67-5.68) and azithromycin (ROR, 13.89; 95% CI, 5.88-32.82), with most reports submitted by other healthcare professionals. CONCLUSIONS: Trimethoprim/sulfamethoxazole may be linked to an increased risk of HLH. Further pharmacoepidemiologic research is necessary to confirm these findings and inform the safe clinical use of trimethoprim/sulfamethoxazole.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.013
metaresearch head score (Gemma)0.049
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.023
Threshold uncertainty score0.071

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0130.049
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0020.003
Bibliometrics0.0230.013
Science and technology studies0.0010.001
Scholarly communication0.0020.002
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.026
GPT teacher head0.364
Teacher spread0.338 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Antimicrobial ChemotherapySame topicAutoimmune and Inflammatory Disorders ResearchFrench-language works237,207